Roger Grau
Impact in
-
- Cancer Cells and Metastasis
- CAR-T cell therapy research
-
- Cancer Genomics and Diagnostics
Papers in
-
- Glycosylation and Glycoproteins Research 3
- Advanced biosensing and bioanalysis techniques 1
- Protein purification and stability 1
- Pluripotent Stem Cells Research 1
-
- Monoclonal and Polyclonal Antibodies Research 4
- Radiopharmaceutical Chemistry and Applications 2
- Co-authors
- Wolfram Trudo Knoefel (1 shared paper)Andreas Erbersdobler (1 shared paper)Stefan B. Hosch (1 shared paper)Christoph A. Klein (1 shared paper)Jakob R. Izbicki (1 shared paper)Uta Reichelt (1 shared paper)Pablo Emilio Verde (1 shared paper)Claudia Hartmann (1 shared paper)
- Journals
- Blood (2 papers)Molecular Immunology (2 papers)Cancer Cell (1 paper)Cancer Research (1 paper)European Journal of Cancer Supplements (1 paper)
- Partner nations
- SwitzerlandGermanyUnited Kingdom
In The Last Decade
Roger Grau
9 papers receiving 299 citations
Peers
Comparison fields: 5 of 46
- Oncology 145
- Cancer Research 74
- Radiology, Nuclear Medicine and Imaging 78
- Genetics 31
- Immunology 63
Countries citing papers authored by Roger Grau
This map shows the geographic impact of Roger Grau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger Grau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger Grau more than expected).
Fields of papers citing papers by Roger Grau
This network shows the impact of papers produced by Roger Grau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger Grau. The network helps show where Roger Grau may publish in the future.
Co-authors
The 25 scholars most cited alongside Roger Grau, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 163 | |
| 2 | 2014 | 45 | |
| 3 | 2006 | 44 | |
| 4 | 2011 | 30 | |
| 5 | 2005 | 11 | |
| 6 | 1997 | 6 | |
| 7 | 2005 | 4 | |
| 8 | GA201, a novel humanized, glycoengineered EGFR antibody with enhanced ADCC and superior in vivo efficacy in xenograft models | 2008 | 3 |
| 9 | 2008 | 2 |
About Roger Grau
Roger Grau is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging, Oncology, Genetics and Surgery, having authored 9 papers that have together received 308 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (4 papers), Glycosylation and Glycoproteins Research (3 papers), Radiopharmaceutical Chemistry and Applications (2 papers), Advanced biosensing and bioanalysis techniques (1 paper), Protein purification and stability (1 paper), Pancreatic and Hepatic Oncology Research (1 paper), Telomeres, Telomerase, and Senescence (1 paper) and Pluripotent Stem Cells Research (1 paper). The work is most often cited by research in Oncology (145 citations), Cancer Research (74 citations), Radiology, Nuclear Medicine and Imaging (78 citations), Genetics (31 citations) and Immunology (63 citations). Roger Grau has collaborated with scholars based in Switzerland, Germany and United Kingdom. Frequent co-authors include Wolfram Trudo Knoefel, Andreas Erbersdobler, Stefan B. Hosch, Christoph A. Klein, Jakob R. Izbicki, Uta Reichelt, Pablo Emilio Verde, Claudia Hartmann, Nikolas H. Stoecklein and Paulus Schurr. Their work appears in journals such as Blood, Molecular Immunology, Cancer Cell, Cancer Research and European Journal of Cancer Supplements.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.